Pilot Study Identifies CSF Metabolomic Biomarkers for Symptoms of Cognitive Impairment during Treatment for Pediatric Acute Lymphoblastic Leukemia
Publication
, Conference
Brown, AL; Raghubar, KP; Taylor, OA; Moore, IM; Rodgers, CC; Hooke, MC; Pan, W; Hockenberry, MJ; Scheurer, ME; Lupo, PJ
Published in: PEDIATRIC BLOOD & CANCER
November 1, 2017
Duke Scholars
Published In
PEDIATRIC BLOOD & CANCER
EISSN
1545-5017
ISSN
1545-5009
Publication Date
November 1, 2017
Volume
64
Start / End Page
S65 / S65
Publisher
WILEY
Related Subject Headings
- Oncology & Carcinogenesis
- 3213 Paediatrics
- 3211 Oncology and carcinogenesis
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Brown, A. L., Raghubar, K. P., Taylor, O. A., Moore, I. M., Rodgers, C. C., Hooke, M. C., … Lupo, P. J. (2017). Pilot Study Identifies CSF Metabolomic Biomarkers for Symptoms of Cognitive Impairment during Treatment for Pediatric Acute Lymphoblastic Leukemia. In PEDIATRIC BLOOD & CANCER (Vol. 64, pp. S65–S65). WILEY.
Brown, A. L., K. P. Raghubar, O. A. Taylor, I. M. Moore, C. C. Rodgers, M. C. Hooke, W. Pan, M. J. Hockenberry, M. E. Scheurer, and P. J. Lupo. “Pilot Study Identifies CSF Metabolomic Biomarkers for Symptoms of Cognitive Impairment during Treatment for Pediatric Acute Lymphoblastic Leukemia.” In PEDIATRIC BLOOD & CANCER, 64:S65–S65. WILEY, 2017.
Brown AL, Raghubar KP, Taylor OA, Moore IM, Rodgers CC, Hooke MC, et al. Pilot Study Identifies CSF Metabolomic Biomarkers for Symptoms of Cognitive Impairment during Treatment for Pediatric Acute Lymphoblastic Leukemia. In: PEDIATRIC BLOOD & CANCER. WILEY; 2017. p. S65–S65.
Brown, A. L., et al. “Pilot Study Identifies CSF Metabolomic Biomarkers for Symptoms of Cognitive Impairment during Treatment for Pediatric Acute Lymphoblastic Leukemia.” PEDIATRIC BLOOD & CANCER, vol. 64, WILEY, 2017, pp. S65–S65.
Brown AL, Raghubar KP, Taylor OA, Moore IM, Rodgers CC, Hooke MC, Pan W, Hockenberry MJ, Scheurer ME, Lupo PJ. Pilot Study Identifies CSF Metabolomic Biomarkers for Symptoms of Cognitive Impairment during Treatment for Pediatric Acute Lymphoblastic Leukemia. PEDIATRIC BLOOD & CANCER. WILEY; 2017. p. S65–S65.
Published In
PEDIATRIC BLOOD & CANCER
EISSN
1545-5017
ISSN
1545-5009
Publication Date
November 1, 2017
Volume
64
Start / End Page
S65 / S65
Publisher
WILEY
Related Subject Headings
- Oncology & Carcinogenesis
- 3213 Paediatrics
- 3211 Oncology and carcinogenesis
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences